Covered recipient · General Payments record
GLEN RAMSAY JR.
Allopathic & Osteopathic Physicians Psychiatry & Neurology Psychosomatic Medicine
General Payments · PY2023–2024
$962.50
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $872.14 | 34 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $374.16 | 21 |
| EMD Serono, Inc. | $255.62 | 3 |
| TG THERAPEUTICS, INC. | $91.12 | 4 |
| Amgen Inc. | $51.88 | 2 |
| SK Life Science, Inc. | $31.42 | 1 |
| Lilly USA, LLC | $26.96 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.42 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.56 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (34)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $26.04 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369914 | CMS |
| ABBVIE INC. | $29.00 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369918 | CMS |
| ABBVIE INC. | $17.43 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369922 | CMS |
| ABBVIE INC. | $28.36 | 01/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369926 | CMS |
| ABBVIE INC. | $7.11 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369930 | CMS |
| ABBVIE INC. | $6.65 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369934 | CMS |
| ABBVIE INC. | $8.92 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369938 | CMS |
| ABBVIE INC. | $27.39 | 03/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369942 | CMS |
| ABBVIE INC. | $6.95 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369946 | CMS |
| ABBVIE INC. | $15.69 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369950 | CMS |
| ABBVIE INC. | $14.18 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369955 | CMS |
| ABBVIE INC. | $12.94 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369959 | CMS |
| ABBVIE INC. | $26.75 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369962 | CMS |
| ABBVIE INC. | $7.30 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369966 | CMS |
| ABBVIE INC. | $12.68 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369971 | CMS |
| ABBVIE INC. | $24.81 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369975 | CMS |
| ABBVIE INC. | $29.89 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369979 | CMS |
| ABBVIE INC. | $7.13 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369983 | CMS |
| ABBVIE INC. | $20.89 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369987 | CMS |
| ABBVIE INC. | $14.49 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369991 | CMS |
| ABBVIE INC. | $29.56 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105369995 | CMS |
| Amgen Inc. | $23.83 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111684002 | CMS |
| Amgen Inc. | $28.05 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111684007 | CMS |
| EMD Serono, Inc. | $143.21 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120236828 | CMS |
| EMD Serono, Inc. | $30.34 | 04/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120220293 | CMS |
| EMD Serono, Inc. | $82.07 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120213174 | CMS |
| Lilly USA, LLC | $26.96 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1134978356 | CMS |
| Novartis Pharmaceuticals Corporation | $25.42 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087316629 | CMS |
| SK Life Science, Inc. | $31.42 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154135060 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $15.56 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137659137 | CMS |
| TG Therapeutics, Inc. | $23.58 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136878304 | CMS |
| TG Therapeutics, Inc. | $14.67 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136878324 | CMS |
| TG Therapeutics, Inc. | $31.67 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136878428 | CMS |
| TG Therapeutics, Inc. | $21.20 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136878384 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.